01_Vorlagen - Swiss Biotech Day

In case of a cancellation of the event due to COVID-19, we will refund the complete amount of the payment.

Partnering

Partnering is already open. Once you have submitted your request for registration, you will receive an automated acknowledgement to the email address you have registered with. By registering for this event we will create a free account in the Swiss Biotech Day online partnering system called “Hello Partnering”. Once your account is set up you will receive a confirmation email containing your login details.

Full partnering will be available on 15 Mar 2023.

If you have any difficulty registering or have not received this acknowledgment, please contact support@hellopartnering.com. Meetings will be held on-site only in a dedicated area of the conference. Click here to access your HelloPartnering account.

sponsored by

You can still log into the partnering system called “Hello Partnering” for the event of 2023 for the next 6 months if you have registered.

You can still search, make new (meeting) requests and use the messenger. In the messenger you can see all existing meetings and open requests and you have the possibility to send messages.

Click here to access your HelloPartnering account. If you have any difficulty registering, or have not received this acknowledgment, please contact support@hellopartnering.com

Moderator: Monika Jones

09:30	Welcome Address Michael Altorfer, CEO, Swiss Biotech Association
09:40	Global trends in biopharmaceutical innovation and outlook Alexandra Zemp, Partner, McKinsey Isma Hachi, Director Emerging BioPharma, IQVIA Daniel Chancellor, Consulting Director, Citeline Maurice Perrinjaquet, Partner, EY
10:10	Swiss Biotech Report 2023 Frederik Schmachtenberg, Partner, Global Life Sciences Lead for Financial Accounting Advisory Services, EY
10:30	Keynote by George Scangos, member of the Board of Directors at Vir Biotechnology George Scangos, Ph.D., has served as a member of the Vir Biotechnology Board of Directors since January 2017. He was the President and Chief Executive Officer of Vir from 2016 to 2023. From 2010 to 2016, he was Chief Executive Officer and a member of the board of directors of Biogen Inc., a publicly traded biopharmaceutical company focused on the treatment of serious diseases. From 1996 to 2010, he served as President and Chief Executive Officer of Exelixis, Inc., a drug discovery and development company. As President of Bayer Biotechnology, from 1993 to 1996, he was responsible for research, business development, process development, manufacturing, engineering, and quality assurance of Bayer Biotechnology’s biological products. Prior to joining industry, Dr. Scangos was a Professor of Biology at Johns Hopkins University and has also served on the board of various publicly traded companies.
11:00	Swiss Biotech Success Stories Award Luca Bolliger, jury president
11:20	Celebrating 25 years of the Swiss Biotech Association Cake Cutting Ceremony

Hotels

You will find an overview of the available accommodation on a daily basis here.

In addition we have special conditions to some partner hotels. Please use the code word “SWISS BIOTECH DAY” (capital letters!) by booking the rooms.

Hotels

Please find here an overview about some hotel partners.

In addition, you will find an overview of the available accommodation on a daily basis here.

Explore the mentoring booths from Bayer, CSL Behring, and Swissmedic, offering personalized guidance to participants. Take the opportunity to gain insights from industry leaders and enhance your professional journey. You can also book a slot via our partnering system.

Contact

Christian Böhm

+41 52 569 82 27

marketing@biocom.de